Sunday, June 10, 2012 11:58:15 AM
ANYONE that puts the packaging issue in perspective for even 1 minute, thats all it takes to conclude that ECONOMICS has zero to do with samples&packaging in the case of PHAR.
If so, how do you explain putting $87,000 down on a building, that the specifics of how to pay for were not worked out, payed out close to $100,000 grand and skipped out on $18,000.
NOW THATS WHERE THE ECONOMICS card can be played, not on samples, to present product in the most proffessional manner possible to medical field, retail etc.
If he has a small lab as openly quoted by CEO many times, samples of his product that he is pushing for funding, should be very high up on priority to put a good face on his product.
Batch size claim that caused ridiculous, "open another companies product, crush and blend some of his and cover right over label and reseal",, well that just fails the ECONOMIC test and passes the fraud & unproffessional test.IMO
Good ECONOMICS and Intellegent approach to achieve phase funding after IPO would be to have took that $100,000 blown on a building and could have took care of most critical area of all to put forth product in the best position to raise funds.
3RD PARTY VALIDATION of AQUAPRIN. Good economics would have been to take $8 to $10,000 to get validation (this is not clinical trails) instead of putting $87,000 down on a building ,would be 10000times more valuable to be a catalyst to raise funds after IPO, than getting in a building with no realistic measures in place to be able to stay, other than hoping one of the fake PRs would cause a SP spike,, (unable to even produce samples) COULD EVER DO.
Instead of using good economics of using funding to get first priorities done and behind you, Validation by 3rd party that this is the product i claim it to be, putting forth the best effort on presentation to public which includes proffessional samples, CEO has and still uses the other method "BEG &BLAME...
Beg for funding and investors to invest in a product that I SAY does work, but not yet tested.. EVERY PR put out fails to help SP or BANKS turn PHAR down,, so CEO/HOWARD blames it on the evil force behind message boards. NEVER considers game plan is all wrong, or does CEO know something he is not telling ..
Exclamation point!!!!!!!!!!
CBD Life Sciences Inc. (CBDL) Launches High-Demand Mushroom Gummy Line for Targeted Wellness Needs, Tapping into a Booming $20 Billion Market • CBDL • Oct 31, 2024 8:00 AM
Nerds On Site Announces Q1 Growth and New Initiatives for the Remainder of 2024 • NOSUF • Oct 31, 2024 7:01 AM
Innovation Beverage Group Receives Largest Shipment of its Top-Selling Bitters to Date in the U.S.-Ready to Meet Growing Demand from Expanding Distribution Network • IBG • Oct 30, 2024 12:22 PM
Element79 Gold Corp to Update Investors on the Emerging Growth Conference on October 31, 2024 • ELMGF • Oct 30, 2024 9:08 AM
CBD Life Sciences Inc. (CBDL) Announces Grand View Research Report Findings on High - Growth CBD Equine Market, Aiming to Drive Unprecedented Shareholder Value • CBDL • Oct 29, 2024 10:19 AM
Integrated Ventures Announces Partnership And Lease Agreement with Driptide Wellness - Leading Health and Wellness Provider. • INTV • Oct 29, 2024 8:45 AM